Related Experiment Video
Updated: Aug 6, 2026

10:12
Characterization and Functional Prediction of Bacteria in Ovarian Tissues
Published on: October 23, 2021
Artificial intelligence in microbiome data analysis: Applications in head and neck cancer
Burçin Kurt1, Adetola Emmanuel Babalola2, Akhilanand Chaurasia3
1Department of Biostatistics and Medical Informatics, Faculty of Medicine, Karadeniz Technical University, Trabzon, Türkiye.
Advances in Immunology
|July 22, 2026
Summary
Artificial intelligence (AI) analyzes head and neck cancer (HNC) microbiome data for biomarker discovery and early diagnosis. AI integration with multi-omics and clinical data advances precision oncology.
Area of Science:
- Oncology
- Microbiome Research
- Artificial Intelligence
Background:
- Head and neck cancer (HNC) research is increasingly leveraging microbiome data.
- Understanding the role of the microbiome in HNC pathogenesis and progression is crucial.
Purpose of the Study:
- To review AI-driven approaches for analyzing microbiome data in HNC.
- To highlight AI's role in biomarker identification, treatment outcome prediction, and early diagnosis.
- To discuss challenges and future directions for AI in HNC precision oncology.
Main Methods:
- Review of artificial intelligence (AI) methodologies, including machine learning and deep learning.
- Integration of multi-omics and clinical data with high-dimensional microbiome profiles.
- Analysis of AI's application in identifying microbial biomarkers and predicting treatment responses.
Main Results:
- AI enables novel analytical strategies for microbiome-based HNC research.
- AI facilitates the integration of diverse datasets for improved disease characterization.
- AI-driven approaches show promise for biomarker discovery and clinical decision-making.
Conclusions:
- AI-driven microbiome analysis offers significant potential for advancing precision oncology in HNC.
- Addressing challenges like data heterogeneity and model interpretability is key for clinical applicability.
- Future directions involve further integrating AI with multi-omics and clinical data for enhanced HNC management.
